<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 27-year-old woman with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibody syndrome, whose first pregnancy had ended in intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo>, was treated with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> 0.6 mg/kg/day before second pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Suppression of anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody activity was rapidly achieved and maintained during the pregnancy </plain></SENT>
<SENT sid="2" pm="."><plain>After conception, low-dose aspirin 81 mg/day was started and continued until delivery </plain></SENT>
<SENT sid="3" pm="."><plain>She gave birth to a <z:mpath ids='MPATH_458'>normal</z:mpath> live infant with natural full-term delivery </plain></SENT>
<SENT sid="4" pm="."><plain>It is strongly suggested that the <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> and low-dose aspirin regimen can lead to successful pregnancy in cases with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibody syndrome like the present case </plain></SENT>
</text></document>